
-   `Title:` [[physiatry23 bone health]]
-   `Type:` [[=]]
-   `Tags:` #🧠️/📝️/🌱️ 
-   `Formation Date:` [[2023-02-24]]
---
# Aurellia
Vit D +calcium - Institure of medicine(IOM) guidelines
baseline vit D status determine dosing
- children to adult: 600 / 70세 이상 800
- calcium - 자료 찾아보자 5~600 

## First line Treatment
BP - not to exceed 5yr oral / 3yr IV, caution in renal disease
Denosumab - missed dosing can increase Vertebral fracutre(2~3month 였다 실험은..그래서 few weeks 넘지 않도록 하자), prior lab obtain(hypocalcemia?)

prevent vertebral & non-vertebral fx include hip
increase in atypical hip Fx. (subtrochanteric) - oversuppresion phenomenon
Jaw osteonecrosis - 치과진료시에 치과의사에게 알리고 biannual medication하는것.

## bone formation stimulator
Forteo (rhPTH 1-34; Teriparatide) - 20mg subq daily 2yr
hypogonadal osteoporosis or primary at high risk for fracure in men
in women: post menopausal / high risk
black box warning for osteosarcoma
1st line 보다 bone formation 많이 함.

Tymlos
post menopausal high risk pts 에서 승인됨.

Evenity (Romosozumab)
anabolic agent, monoclonal antibody..
AE: cardiovascular death, Heart attack, stroke


1st line 에 실패하거나 recurrent fracture 있으면 anabolic 사용 고려하는데 보통 포스테오 티믈로스로 시작한다.
이베니티는 위험요소가 더 많지만 여전히 옵션이다.

# Young athletes - michael fredericson

Wolff's law



🔗LINKS TO THIS PAGE